VERTEX CELL AND GENETIC THERAPIES Trademark

Trademark Overview


On Thursday, March 12, 2020, a trademark application was filed for VERTEX CELL AND GENETIC THERAPIES with the United States Patent and Trademark Office. The USPTO has given the VERTEX CELL AND GENETIC THERAPIES trademark a serial number of 88832541. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 23, 2023. This trademark is owned by Vertex Pharmaceuticals Incorporated. The VERTEX CELL AND GENETIC THERAPIES trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

house mark for pharmaceutical preparations; nucleic acid medicines for the treatment of genetic diseases and disorders; pharmaceutical preparations for the treatment of genetic diseases and disorders; pharmaceutical preparations for the treatment of muscular dystrophy

medical and scientific research in the field of gene therapy; medical and scientific research in the field of nucleic acid; medical and scientific research in the field of gene editing for developing cells and pharmaceuticals for medical and clinical use; research and development of pharmaceuticals using gene editing
vertex cell and genetic therapies

General Information


Serial Number88832541
Word MarkVERTEX CELL AND GENETIC THERAPIES
Filing DateThursday, March 12, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 23, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 28, 2020

Trademark Statements


Goods and Serviceshouse mark for pharmaceutical preparations; nucleic acid medicines for the treatment of genetic diseases and disorders; pharmaceutical preparations for the treatment of genetic diseases and disorders; pharmaceutical preparations for the treatment of muscular dystrophy
Disclaimer with Predetermined Text"CELL AND GENETIC THERAPIES"
Goods and Servicesmedical and scientific research in the field of gene therapy; medical and scientific research in the field of nucleic acid; medical and scientific research in the field of gene editing for developing cells and pharmaceuticals for medical and clinical use; research and development of pharmaceuticals using gene editing

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 18, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, March 18, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameVertex Pharmaceuticals Incorporated
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02210

Party NameVertex Pharmaceuticals Incorporated
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02210

Trademark Events


Event DateEvent Description
Monday, October 23, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 23, 2023ABANDONMENT - NO USE STATEMENT FILED
Wednesday, March 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 7, 2023SOU EXTENSION 5 GRANTED
Wednesday, February 22, 2023SOU EXTENSION 5 FILED
Tuesday, March 7, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 22, 2023SOU TEAS EXTENSION RECEIVED
Thursday, July 28, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 26, 2022SOU EXTENSION 4 GRANTED
Tuesday, July 26, 2022SOU EXTENSION 4 FILED
Tuesday, July 26, 2022SOU TEAS EXTENSION RECEIVED
Friday, February 18, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 16, 2022SOU EXTENSION 3 GRANTED
Wednesday, February 16, 2022SOU EXTENSION 3 FILED
Wednesday, February 16, 2022SOU TEAS EXTENSION RECEIVED
Friday, August 20, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 18, 2021SOU EXTENSION 2 GRANTED
Wednesday, August 18, 2021SOU EXTENSION 2 FILED
Wednesday, August 18, 2021SOU TEAS EXTENSION RECEIVED
Saturday, January 23, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 21, 2021SOU EXTENSION 1 GRANTED
Thursday, January 21, 2021SOU EXTENSION 1 FILED
Thursday, January 21, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, September 22, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 28, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 28, 2020PUBLISHED FOR OPPOSITION
Wednesday, July 8, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sunday, June 21, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 17, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 17, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 17, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, June 7, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, June 7, 2020NON-FINAL ACTION E-MAILED
Sunday, June 7, 2020NON-FINAL ACTION WRITTEN
Wednesday, June 3, 2020ASSIGNED TO EXAMINER
Wednesday, March 18, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 16, 2020NEW APPLICATION ENTERED